SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the
month of July, 2025
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
13/F, One International Finance Centre,
1 Harbour View Street, Central,
Hong Kong, China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover Form 20-F or Form 40-F.
Form
20-F X
Form 40-F
Indicate
by check mark whether the registrant by furnishing the
information
contained
in this Form is also thereby furnishing the information to
the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes
No X
If
"Yes" is marked, indicate below the file number assigned to the
registrant
in
connection with Rule 12g3-2(b): 82-
Prudential plc Board changes
Prudential plc ("Prudential", the "Company") announces the following changes to its Board of
Directors:
Appointment of Dr Guido Fürer as a Non-executive
Director
Dr Guido Fürer has been appointed to the Board with immediate
effect. He will also be a member of the Audit and Risk
Committees.
Dr Fürer has extensive international experience of the
insurance and asset management industries. His 25-year career at
Swiss Re Group included 11 years as Group Chief Investment Officer
and member of the Global Executive Committee, heading up the Global
Asset Management division, as well as a term as Country President,
Switzerland, and Chair of the Group Strategic Council. Prior to
joining Swiss Re, Dr Fürer held leading positions at Swiss
Bank Corp /O'Connor and Associates in options trading and capital
markets.
Between 2018 and 2022 Dr Fürer was a non-executive director,
and chaired the Group Risk Committee, of FWD Group, gaining insight
into various of Prudential's key markets. He is currently a
non-executive director of Baloise Group and chair of its Risk &
Investment Committee.
Retirement of Amy Yip
Following the completion of six years in office, Amy Yip will
retire from the Board with effect from 31 October 2025. Ms Yip
joined the Board in September 2019. She has been a member of the
Audit Committee since March 2021 and prior to that was a member of
the Remuneration Committee.
Shriti Vadera, Chair of Prudential, said: "Guido brings a wealth of
knowledge and expertise, including in respect of asset management,
insurance and asset-liability management, from both a distinguished
executive career and from his global board experience. I am
delighted to welcome him on to the Board".
"At the same time, we will be sorry to lose Amy later in the year
after six years on the Board. On behalf of the Board, I would like
to take the opportunity to thank Amy for her valuable contribution
in helping the Board to guide and oversee the Group through a
period of significant change."
Contact
|
Media
|
Investors/analysts
|
||
|
Simon Kutner
|
+44 7581 023260
|
Patrick Bowes
|
+852 2918 5468
|
|
Sonia Tsang
|
+852 5580 7525
|
William Elderkin
|
+44 20 3977 9215
|
|
|
|
Ming Hau
|
+44 20 3977 9293
|
|
|
|
Bosco Cheung
|
+852 2918 5499
|
|
|
|
Tianjiao Yu
|
+852 2918 5487
|
Notes to Editors
About Guido Fürer
Dr Fürer has over three decades of international experience
across financial services. He began his career with Swiss Bank
Corporation/O'Connor & Associates in options trading and in its
Capital Markets division in Chicago, New York, London and Zurich.
In 1997 he joined Swiss Re, where he held various positions before
being appointed Group Chief Investment Officer and member of the
Group Executive Committee in 2012, heading up Group Asset
Management until his retirement in March 2023.
Between 2019 and 2023, Dr Fürer served as Country President,
Swiss Re Switzerland, and held the roles of Chair of Swiss Re's
Strategic Council, Zurich Pension Fund, and Trustee of the Swiss Re
Foundation.
During his time at Swiss Re Dr Fürer served on the boards of a
number of subsidiary entities and, from 2018 to 2022, as a
non-executive director of pan-Asian insurer FWD Group, where he
chaired the Group Risk Committee. In addition, he played a
significant role in the establishment of the UN-enabled Net-Zero
Asset Owner Alliance.
Following his retirement, Dr Fürer became a member of the
board of insurance and banking group Baloise Holding AG in April
2024, becoming Chair of the Risk & Investment Committee in
April 2025.
Dr Fürer has a master's degree in Economics and a doctorate in
Financial Risk Management from the University of Zurich, where he
is now Chair of the Advisory Board of the Department of
Finance.
Age
61
Shareholding
Dr Fürer does not hold any interest in shares of Prudential
plc.
Length of service
Non-executive Directors are usually appointed for an initial
three-year term. They are typically expected to serve for two
three-year terms, although the Board may invite them to serve for
an additional period.
Remuneration
Non-executive Directors are not eligible to participate in annual
bonus plans, long-term incentive plans or pension arrangements.
Their fees are determined by the Board and reflect their individual
responsibilities, including committee membership as
appropriate.
On appointment, Dr Fürer will receive the standard annual
Non-executive Director fee of $125,000, in addition to which he
will receive an additional annual fee of $39,000 for his membership
of the Audit Committee and an additional annual fee of $39,000 for
his membership of the Risk Committee.
Regulatory Disclosures
Dr Fürer is considered independent for the purposes of the UK
Corporate Governance Code and the Rules Governing the Listing of
Securities on The Stock Exchange of Hong Kong Limited (Hong Kong
Listing Rules).
Dr Fürer has confirmed (a)his independence as regards each of
the factors referred to in Hong Kong Listing Rule 3.13; (b) he does
not have any past or present financial or other interest in the
business of the Company or its subsidiaries or any connection with
any core connected person of the Company (as defined by the Hong
Kong Listing Rules). and (c) there are no other factors that may
affect his independence at the time of his
appointment.
Dr Fürer has also joined the Board of Prudential Corporation
Asia Limited, a wholly owned subsidiary of Prudential, with
immediate effect. Dr Fürer has confirmed to the Company that
all of the biographical and other relevant information required by
UK Listing Rules 6.4.8R - 6.4.10G and / or Hong Kong Listing Rule
13.51(2) has been disclosed in full and that those details are
true, accurate and complete. The Company is not aware of any other
matters in relation to his appointment or otherwise that need to be
brought to the attention of Prudential's shareholders.
Ms Yip has confirmed to the Company that she has no disagreement
with the Board and that there are no matters that need to be
brought to the attention of Prudential's shareholders in respect of
her resignation.
About Prudential plc
Prudential provides life and health insurance and asset management
in 24 markets across Asia and Africa. Prudential's mission is to be
the most trusted partner and protector for this generation and
generations to come, by providing simple and accessible financial
and health solutions. The business has dual primary listings on the
Stock Exchange of Hong Kong (2378) and the London Stock Exchange
(PRU). It also has a secondary listing on the Singapore Stock
Exchange (K6S) and a listing on the New York Stock Exchange (PUK)
in the form of American Depositary Receipts. It is a constituent of
the Hang Seng Composite Index and is also included for trading in
the Shenzhen-Hong Kong Stock Connect programme and the
Shanghai-Hong Kong Stock Connect programme.
Prudential is not affiliated in any manner with Prudential
Financial, Inc. a company whose principal place of business is in
the United States of America, nor with The Prudential Assurance
Company Limited, a subsidiary of M&G plc, a company
incorporated in the United Kingdom.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date: 01
July 2025
|
|
PRUDENTIAL
PUBLIC LIMITED COMPANY
|
|
|
|
|
|
By: /s/ Thomas Clarkson
|
|
|
|
|
|
Thomas
Clarkson
|
|
|
Company
Secretary
|